DIM
IART icon

DC Investments Management’s Integra LifeSciences IART Stock Holding History

DC Investments Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,040
Closed -$284K – 177
2020
Q2 		$284K Buy
+6,040
New +$297K 0.1% 239

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

DC Investments Management's IART Position: Q3 2020 in Review

DC Investments Management sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 6,040 shares — an estimated $284K sold.

DC Investments Management first reported a position in IART in Q2 2020 and held it in 1 quarter. The position peaked at $284K in Q2 2020. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

  • DC Investments Management reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 6,040 Integra LifeSciences shares in Q3 2020, an estimated $284K.
  • DC Investments Management first reported a position in Integra LifeSciences in Q2 2020 and held it in 1 quarter.
  • DC Investments Management's Integra LifeSciences position peaked at $284K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.